10x Genomics Acquires Proteintech Genomics Division
Reported by Dow Jones Newswires
Sentiment
Neutral
Importance
8
Price
$29.5
Mkt Cap
$3.705B
52W Low
$9.21
52W High
$35.645
Market data snapshot near publication time
Summary
10x Genomics has acquired Proteintech Genomics, a division of Proteintech Group. This strategic acquisition follows the company's Q1 earnings report in early May, which highlighted reduced losses and the launch of its new Atera platform. The move indicates 10x Genomics is actively expanding its portfolio and capabilities within the genomics sector, potentially impacting future growth and market position.
At the time of this announcement, TXG was trading at $29.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $9.21 to $35.65. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.
Price Chart
TXG - Latest Insights
TXG
Jun 09, 2026, 9:00 AM EDT
Price at Filing:
$29.50
Real-time Price:
$29.60
Change:
+$0.100 (+0.34%)
Market Cap:
$3.661B
TXG
May 07, 2026, 5:36 PM EDT
Price at Filing:
$21.46
Real-time Price:
$29.60
Change:
+$8.14 (+38%)
Market Cap:
$3.661B
TXG
May 07, 2026, 4:24 PM EDT
Price at Filing:
$21.50
Real-time Price:
$29.60
Change:
+$8.10 (+38%)
Market Cap:
$3.661B
TXG
May 07, 2026, 4:03 PM EDT
Price at Filing:
$22.02
Real-time Price:
$29.60
Change:
+$7.58 (+34%)
Market Cap:
$3.661B
TXG
Feb 12, 2026, 5:38 PM EST
Price at Filing:
$17.57
Real-time Price:
$29.60
Change:
+$12.03 (+68%)
Market Cap:
$3.661B
TXG
Feb 12, 2026, 4:09 PM EST
Price at Filing:
$17.51
Real-time Price:
$29.60
Change:
+$12.09 (+69%)
Market Cap:
$3.661B
TXG
Jan 12, 2026, 3:52 PM EST
Price at Filing:
$19.70
Real-time Price:
$29.60
Change:
+$9.91 (+50%)
Market Cap:
$3.661B